Company intelligence / Profile preview

Heyu

Ownership: Private
Development stage: Phase 1

Overview

Heyu Biological Technology Corp is a Nevada-incorporated holding company that previously aimed to research, develop, manufacture, and sell healthcare equipment ("Chamber") and various natural plant-based health products. As of the most recent filings in June 2023, the company reports having no ongoing business operations. Its long-term strategy had included mass production of medical chambers for both individual and institutional customers as well as expansion into consumer health markets with supplements and cosmetics. The company operates through subsidiaries in China but is itself a US holding entity.

Modalities: Medical devices/equipment ("Chamber")Natural plant-based health products, cosmetics, nutritional supplements, and drugs
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

HY01

Phase 1

Indications: Sudden sensorineural hearing loss, Deafness

Beyond the preview

Go deeper on Heyu.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heyu.

Explore the full profile